FDA advisory panelist outlines issues with aducanumab’s approval for Alzheimer’s disease

Despite near unanimous objection from its advisory panel, the U.S. Food and Drug Administration (FDA) granted aducanumab approval to treat Alzheimer’s disease on June 7, 2021. In a commentary published in Annals of Internal Medicine, a member and former Chair of the advisory panel and an aducanumab site investigator explain why this unprecedented “accelerated approval” […]

Continue Reading

Tai chi shows promise for relief of depression and anxiety in stroke survivors

A small feasibility study has suggested that tai chi has the potential to reduce depression, anxiety and stress plus improve sleep in people who have had a stroke. The research is presented today at EuroHeartCare—ACNAP Congress 2021, an online scientific congress of the European Society of Cardiology (ESC). Depression occurs in approximately one-third of stroke […]

Continue Reading